| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Non steroidal anti inflammatory drugsNephrotoxicityKidney (Analgesics nephropathy)Liver (Toxicology)LumiracoxibEtodolacMeloxicamCelecoxibRofecoxibEtoricoxibValdecoxibAdhesion (Surgery)Ductus botalliPrenatal diagnostics| 1 | 2003 | Hepatocellular damage from non-steroidal anti-inflammatory drugs. | 
| + | - | nl | QJM 96(11):787-91 (2003) |
| 2 | 2007 | An evidence-based update on nonsteroidal anti-inflammatory drugs. |
| + | - | nl | Clin Med Res 5(1):19-34 (2007) |
| 3 | 2003 | Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. |
| + | - | nl | J Intern Med 253(6):643-52 (2003) |
| 4 | 1993 | NSAIDs. Are there any differences? |
| + | - | nl | Arch Fam Med 2(11):1167-74 (1993) |
| 5 | 1999 | Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. |
| + | - | nl | Br J Clin Pharmacol 47(2):203-10 (1999) |
| 6 | 1979 | The third Lilly Prize Lecture. University of London, January, 1979. The nephrotoxicity and hepatotoxicity of antipyretic analgesics. | 
| + | - | nl | Br J Clin Pharmacol 7(5):453-62 (1979) |
| 7 | 2006 | Hepatotoxicity of anti-inflammatory and analgesic drugs: ultrastructural aspects. |
| + | - | nl | Acta Pharmacol Sin 27(3):259-72 (2006) |
| 8 | 2008 | Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. |
| + | - | nl | J Pharm Pharm Sci 11(2):81s-110s (2008) |
| 9 | 2006 | Relative value of the NSAIDs, including COX-2 inhibitors and meloxicam. |
| + | - | nl | J Manag Care Pharm 12(3):265-8 (2006) |
| 10 | 2008 | Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. |
| + | - | nl | Health Technol Assess 12(11):1-278, iii (2008) |
| 11 | 2006 | A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling. |
| + | - | nl | Health Technol Assess 10(38):iii-iv, xi-xiii, 1-183 (2006) |
| 12 | 1993 | Why are non-steroidal anti-inflammatory drugs so variable in their efficacy? A description of ion trapping. |
| + | - | nl | Ann Rheum Dis 52(3):241-3 (1993) |
| 13 | 1992 | Drug derived radicals: mediators of the side effects of anti-inflammatory drugs? |
| + | - | nl | Ann Rheum Dis 51(11):1261-3 (1992) |
| 14 | 2007 | Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs. |
| + | - | nl | Aliment Pharmacol Ther 25(7):813-21 (2007) |
| 15 | 2006 | Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. |
| + | - | nl | Aliment Pharmacol Ther 24(5):751-67 (2006) |
| 16 | 2004 | Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs. |
| + | - | nl | Aliment Pharmacol Ther 20(4):373-80 (2004) |
| 17 | 2004 | Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract. |
| + | - | nl | Aliment Pharmacol Ther 20(3):321-31 (2004) |
| 18 | 2004 | Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. |
| + | - | nl | Aliment Pharmacol Ther 19(10):1051-61 (2004) |
| 19 | 2001 | Review article: over-the-counter drugs and the gastrointestinal tract. |
| + | - | nl | Aliment Pharmacol Ther 15(9):1263-70 (2001) |
| 20 | 1999 | Review article: nonsteroidal anti-inflammatory drug-associated gastrointestinal complications--guidelines for prevention and treatment. |
| + | - | nl | Aliment Pharmacol Ther 13(10):1273-85 (1999) |
| 21 | 1998 | Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability. |
| + | - | nl | Aliment Pharmacol Ther 12(4):303-20 (1998) |
| 22 | 1998 | Clinical economics review: gastrointestinal complications of non-steroidal anti-inflammatory drugs. |
| + | - | nl | Aliment Pharmacol Ther 12(2):127-33 (1998) |
| 23 | 2009 | Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers. |
| + | - | nl | Aliment Pharmacol Ther 30(6):517-31 (2009) |
| 24 | 2009 | Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks. |
| + | - | nl | Aliment Pharmacol Ther 29(5):481-96 (2009) |
| 25 | 2000 | Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs. |
| + | - | nl | Arthritis Res 2(5):379-85 (2000) |
| 26 | 2008 | Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. |
| + | - | nl | Arthritis Rheum 59(8):1058-73 (2008) |
| 27 | 2004 | The discovery and development of antiinflammatory drugs. |
| + | - | nl | Arthritis Rheum 50(8):2391-9 (2004) |
| 28 | 2007 | Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. |
| + | - | nl | Circulation 115(12):1634-42 (2007) |
| 29 | 2003 | Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. |
| + | - | nl | Gut 52(4):600-8 (2003) |
| 30 | 1997 | Nonsteroidal anti-inflammatory drugs (NSAIDs) and the kidney. |
| + | - | nl | Nephrol Dial Transplant 12(3):386-8 (1997) |
| 31 | 2003 | Underutilization of preventive strategies in patients receiving NSAIDs. |
| + | - | nl | Rheumatology (Oxford) 42 Suppl 3(-):iii23-31 (2003) |
| 32 | 2002 | The hidden costs of arthritis treatment and the cost of new therapy--the burden of non-steroidal anti-inflammatory drug gastropathy. |
| + | - | nl | Rheumatology (Oxford) 41 Supp 1(-):7-15; discussion 35-42 (2002) |
| 33 | 1993 | Renal complications of nonsteroidal anti-inflammatory drugs. |
| + | - | nl | Kidney Int 44(3):643-53 (1993) |
| 34 | 1980 | Renal effects of drugs that inhibit prostaglandin synthesis. |
| + | - | nl | Kidney Int 18(5):609-22 (1980) |
| 35 | 2007 | Determinants of the short-term gastric damage caused by NSAIDs in man. |
| + | - | nl | Aliment Pharmacol Ther 26(1):95-106 (2007) |
| 36 | 2007 | Nonsteroidal anti-inflammatory drug hypersensitivity in preschool children. |
| + | - | nl | Allergy Asthma Clin Immunol 3(4):114-22 (2007) |
| 37 | 2007 | Anti-inflammatory and side effects of cyclooxygenase inhibitors. |
| + | - | nl | Pharmacol Rep 59(3):247-58 (2007) |
| 38 | 2003 | Resolution of multiple severe nonsteroidal anti-inflammatory drug-induced colonic strictures with prednisone therapy: a case report and review of the literature. |
| + | - | nl | Can J Gastroenterol 17(8):497-500 (2003) |
| 39 | 2004 | Prenatal diagnosis of intrauterine premature closure of the ductus arteriosus following maternal diclofenac application. | 
| + | - | nl | Ultrasound Obstet Gynecol 23(5):513-6 (2004) |
| 40 | 2006 | Gastroprotective strategies among NSAID users: guidelines for appropriate use in chronic illness. |
| + | - | nl | Can Fam Physician 52(9):1100-5 (2006) |
